9.75
price down icon0.31%   -0.03
after-market After Hours: 9.75
loading
Anika Therapeutics Inc stock is traded at $9.75, with a volume of 57,296. It is down -0.31% in the last 24 hours and up +3.72% over the past month. Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
See More
Previous Close:
$9.78
Open:
$9.72
24h Volume:
57,296
Relative Volume:
0.52
Market Cap:
$140.58M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-1.9231
EPS:
-5.07
Net Cash Flow:
$1.14M
1W Performance:
-2.60%
1M Performance:
+3.72%
6M Performance:
-32.90%
1Y Performance:
-43.02%
1-Day Range:
Value
$9.72
$9.93
1-Week Range:
Value
$9.585
$10.17
52-Week Range:
Value
$7.8701
$18.37

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
Name
Anika Therapeutics Inc
Name
Phone
(781) 457-9000
Name
Address
32 WIGGINS AVENUE, BEDFORD, MA
Name
Employee
288
Name
Twitter
Name
Next Earnings Date
2025-03-12
Name
Latest SEC Filings
Name
ANIK's Discussions on Twitter

Compare ANIK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
9.75 141.01M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-17-25 Initiated B. Riley Securities Buy
Nov-01-24 Reiterated Barrington Research Outperform
Aug-14-23 Upgrade Barrington Research Mkt Perform → Outperform
Mar-07-23 Downgrade Barrington Research Outperform → Mkt Perform
Nov-09-22 Upgrade Barrington Research Mkt Perform → Outperform
Oct-14-22 Resumed Stephens Equal-Weight
Mar-09-22 Downgrade Barrington Research Outperform → Mkt Perform
Mar-09-22 Downgrade Stephens Overweight → Equal-Weight
Nov-16-21 Initiated Stephens Overweight
Jul-16-21 Initiated UBS Neutral
Dec-16-20 Upgrade Barrington Research Mkt Perform → Outperform
May-08-20 Downgrade Barrington Research Outperform → Mkt Perform
Jan-21-20 Upgrade Sidoti Neutral → Buy
Jan-10-20 Upgrade First Analysis Sec Outperform → Strong Buy
Nov-05-19 Initiated BWS Financial Sell
Sep-24-19 Reiterated Barrington Research Outperform
Sep-23-19 Downgrade First Analysis Sec Strong Buy → Outperform
Jul-25-19 Upgrade First Analysis Sec Neutral → Strong Buy
Feb-22-19 Downgrade First Analysis Sec Outperform → Neutral
Feb-22-19 Downgrade Sidoti Buy → Neutral
Jul-27-18 Upgrade Barrington Research Mkt Perform → Outperform
Jun-20-18 Downgrade Barrington Research Outperform → Mkt Perform
Jun-20-18 Downgrade First Analysis Sec Overweight → Equal-Weight
May-04-18 Upgrade Barrington Research Mkt Perform → Outperform
Feb-23-18 Downgrade Barrington Research Outperform → Mkt Perform
Jan-24-18 Upgrade First Analysis Sec Equal-Weight → Overweight
Oct-27-17 Reiterated Barrington Research Outperform
May-09-16 Upgrade Singular Research BUY - Long-Term → Buy
Apr-27-16 Downgrade Northland Capital Outperform → Market Perform
Feb-26-16 Reiterated Barrington Research Outperform
View All

Anika Therapeutics Inc Stock (ANIK) Latest News

pulisher
12:34 PM

Anika Therapeutics (NASDAQ:ANIK) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

12:34 PM
pulisher
07:06 AM

What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 20252025 EndofYear Setup & Technical Pattern Based Signals - newser.com

07:06 AM
pulisher
06:32 AM

What dividend safety rating applies to Anika Therapeutics Inc. (AKP) stockTrade Ideas & Scalable Portfolio Growth Methods - newser.com

06:32 AM
pulisher
06:02 AM

Key metrics from Anika Therapeutics Inc.’s quarterly data2025 Winners & Losers & Verified Technical Signals - newser.com

06:02 AM
pulisher
05:28 AM

Is Anika Therapeutics Inc. stock supported by strong cash flows2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com

05:28 AM
pulisher
04:41 AM

Why Anika Therapeutics Inc. stock could rally in 2025Weekly Profit Analysis & Breakout Confirmation Alerts - newser.com

04:41 AM
pulisher
02:57 AM

Does Anika Therapeutics Inc. show high probability of reboundJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com

02:57 AM
pulisher
01:39 AM

Why Anika Therapeutics Inc. stock could outperform in 2025Bear Alert & Low Risk High Win Rate Stock Picks - newser.com

01:39 AM
pulisher
01:31 AM

Detecting support and resistance levels for Anika Therapeutics Inc.Inflation Watch & Long Hold Capital Preservation Plans - newser.com

01:31 AM
pulisher
Oct 30, 2025

Is Anika Therapeutics Inc. stock positioned for long term growthTrade Ideas & Risk Managed Investment Entry Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Strategies to average down on Anika Therapeutics Inc.2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

How to escape a deep drawdown in Anika Therapeutics Inc.2025 Growth vs Value & Smart Allocation Stock Reports - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) is a favorite amongst institutional investors who own 60% - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Using AI based signals to follow Anika Therapeutics Inc.Quarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Anika Therapeutics Inc. stock sustain revenue growth2025 Momentum Check & Real-Time Price Movement Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Will Anika Therapeutics Inc. (AKP) stock benefit from sector leadershipMarket Performance Report & Daily Technical Forecast Reports - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Can Anika Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Macro Moves & Fast Gain Swing Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Is Anika Therapeutics Inc. stock attractive for growth ETFsWeekly Gains Summary & Long-Term Safe Investment Ideas - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Anika Therapeutics’ Integrity Implant System Study: A Market Game Changer? - TipRanks

Oct 27, 2025

Anika Therapeutics Inc Stock (ANIK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Anika Therapeutics Inc Stock (ANIK) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Cap:     |  Volume (24h):